Objectives: Nesiritide (synthetic B-type natriuretic peptide) has been shown to be effective in the management of acute decompensated heart failure in adults. The role of nesiritide in pediatric ...
Congestive heart failure (CHF) is the term used to describe what happens when the heart is unable to pump enough blood to meet the body’s needs. (It should not be confused with cardiac arrest in which ...
However, the use of metformin has not been without controversy, in particular in patients with heart failure. This article will review a recent observational study by Aguilar et al. published in ...
“Heart failure in children is particularly challenging. The rarity of donor hearts, especially for infants, combined with the complexities of congenital heart disease, makes it an incredibly ...
Platelets, or cell fragments in blood that help stop or prevent bleeding, tend to cluster in lung blood vessels of people with decompensated pulmonary hypertension (PH), a lung disease characterized ...
Introduction: Pediatric heart failure (HF) 30-Day readmission rates are high (~20%) and contribute to resource utilization. Methods: A quality improvement project was initiated with the aim to reduce ...
It gets worse over time and can lead to heart failure. It can run in your family but can also be caused by many things, including coronary artery disease (CAD), inflammation, infection in your ...
Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...
Scarring of heart tissue can be slowed but not stopped, and can lead to heart failure. But a new study has shown that an existing immunotherapy could stop scar tissue formation after heart attacks.